Bank of New York Mellon’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $10.2M | Sell |
|
|||||
|
2024
Q1 | $12.2M | Sell |
|
|||||
|
2023
Q4 | $13.2M | Buy |
|
|||||
|
2023
Q3 | $5.76M | Buy |
|
|||||
|
2023
Q2 | $8.27M | Buy |
|
|||||
|
2023
Q1 | $5.75M | Buy |
|
|||||
|
2022
Q4 | $7.41M | Buy |
|
|||||
|
2022
Q3 | $6.4M | Buy |
|
|||||
|
2022
Q2 | $5.51M | Sell |
|
|||||
|
2022
Q1 | $14.3M | Sell |
|
|||||
|
2021
Q4 | $14.3M | Buy |
|
|||||
|
2021
Q3 | $12.5M | Buy |
|
|||||
|
2021
Q2 | $9.8M | Sell |
|
|||||
|
2021
Q1 | $11.4M | Buy |
|
|||||
|
2020
Q4 | $359K | Buy |
|